Company profile
swisscann is a leading Swiss company for medical cannabis, headquartered in Zurich, with a state-of-the-art production facility in Glattfelden. Founded in 2017 during the early stages of cannabis legalization, we focus on the production and distribution of THC-containing cannabis products for medical use. As a B2B partner, we focus on the Swiss and EU markets, supplying pharmacies, hospitals, and pharmaceutical companies while enabling patients to access high-quality, GMP-certified medicines. Our commitment: precision, quality, and safety for a modern, evidence-based cannabis therapy.
We hold all necessary regulatory approvals to cultivate, process, and distribute medical cannabis at the highest level. These include authorization for the cultivation of medical cannabis with high THC content, approval for handling narcotics, a license for the production of pharmaceuticals in compliance with EU-GMP standards, and authorization for wholesale distribution to Swiss pharmacies, as well as import and export under GDP regulations. All approvals have been issued by Swissmedic, ensuring that we meet the strictest pharmaceutical and regulatory requirements. This allows us to guarantee our partners in pharmacies, hospitals, and pharmaceutical wholesale maximum quality, safety, and compliance.
Medical Cannabis (THC)
Good Manufacturing Practice (EU-GMP certified)
Wholesale in Switzerland and Import/Export (GDP)
Approval for the cultivation of medical cannabis (THC)
Approval for handling controlled substances
swissness
Production
Our GMP-certified production facility meets the strictest pharmaceutical standards and enables fully integrated processing of medical cannabis – from controlled cultivation and processing to packaging and distribution. The facility was commissioned in 2022 and features a cleanroom environment that ensures the highest quality and product safety. In 2023, we received GMP certification from Swissmedic, and our operational site is regularly inspected and supervised by Swissmedic.
Career at swisscann tec
As a young company, we are in a constant growth process. That’s why we are always looking for new professionals to help us bring our vision to life. We are continuously seeking motivated employees with enthusiasm and innovative ideas to support us in this journey. In return, you will benefit from an exciting field of work and excellent working conditions.
Medical Cannabis
On August 1, 2022, a legal amendment came into effect in Switzerland, allowing the cultivation, production, processing, and export of cannabis for medical purposes. This amendment legally regulates medical cannabis and places it under the approval and control procedures of Swissmedic. Doctors can now prescribe medical cannabis, giving thousands of patients easier access to medical cannabis preparations in pharmacies. This primarily affects cases of cancer or multiple sclerosis, where the active ingredient THC can help relieve chronic pain. This has established the foundation for a regulated and legal market for medical cannabis in Switzerland.
The market for medical cannabis is experiencing strong global growth. More than 45 countries have legalized cannabis for medical purposes, with many others in the process of legalization. As a result, the global medical cannabis market is becoming one of the most attractive future industries. Since 2017, medical cannabis has been approved in Germany and other European countries and is prescribed to patients on prescription. With the legal amendment in Switzerland on August 1, 2022, swisscann tec now has the opportunity to export medical cannabis to other countries.
News Feed
swisscann tec and alephSana: Exclusive Partnership for the Swiss Essence Line in Germany
swisscann tec and alephSana are excited to announce their exclusive partnership. Together, we are bringing the Swiss Essence Line, a new unified product line of GMP-certified medical cannabis products, to Germany.
The Journey to GMP Compliance
We are thrilled to share that our CEO, Daniel Gelemanovic, will be joining a panel at the Cannabis Business Expo and Conference in Dortmund, Germany, from September 19th to 21st, 2024.
Introducing Medical Cannabis Flowers!
We're excited to share that swisscann has officially begun the first cultivation cycle of high-THC medical cannabis flowers at our GMP certified, state-of-the-art production facility in Zurich, Switzerland! This is a proud moment for us and a significant milestone in our company's history.
Medical cannabis industry: Swisscann and GMP certification
Daniel Gelemanovic, CEO of Swisscann Tec AG, shared the news that the company has officially achieved Good Manufacturing Practice (GMP) certification from Swissmedic on December 14, 2023. This remarkable milestone underscores Swisscann’s unwavering commitment to the highest standards in the medical cannabis industry.
Our strengths
swisscann tec